Nano Therapeutics Pvt. Ltd. Hojiwala Industrial Estate, Surat, Gujarat

Xperia coronary Stent System includes 316L Stainless Steel Stent mounted on Rapid Exchange Stent Delivery System (Balloon Catheter) between two platinum iridium radio opaque marker bands. Xperia stent is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease in de novo coronary artery lesion in native coronary arteries with a reference vessel diameter of 2.50 mm to 4.5 mm and a lesion length ≤40 mm. Xperia is intended for use in patients eligible for Percutaneous Transluminal Coronary Angioplasty (PTCA). This latest generation design of Xperia has a unique geometry for controlled & distinctive stent expansion which enables low stent induced mechanical injury to arterial wall and excellent vessel conformability.

We are offering superia sirolimus eluting coronary stent system etc. Superia sirolimus eluting stent system comprises of following components. L605 chromium cobalt alloy stent (platform: flexia) rapid exchange delivery system biodegradable polymers drug sirolimus superia is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease in de novo coronary artery lesion in native coronary arteries with a reference vessel diameter of 2.25 mm to 4.50 mm and a lesion length ≤40 mm. Superia is intended for use in patients eligible for percutaneous transluminal coronary angioplasty (ptca). Latest generation design of flexia (superia platform) has unique geometry for controlled & distinctive stent expansion which enables low stent induced mechanical injury to arterial wall and excellent vessel conformability. Unique geometry of flexia platform allows sirolimus drug to uniformly distribution over its length to control drug elution in a very precise manner which reduces the chances of restenosis.

Flexia Coronary Stent System includes L605 Cobalt Chromium (CoCr alloy) Stent mounted on Rapid Exchange Stent Delivery System (Balloon Catheter) between two platinum iridium radio opaque markers bands. Flexia is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease in de novo coronary artery lesion in native coronary arteries with a reference vessel diameter of 2.25 mm to 4.5 mm and a lesion length ≤40 mm. Flexia is intended for use in patients eligible for Percutaneous Transluminal Coronary Angioplasty (PTCA). This latest generation design of Flexia has a unique geometry for controlled & distinctive stent expansion which enables low stent induced mechanical injury to arterial wall and excellent vessel conformability.

We are offering eternia everolimus eluting stent system etc. L605 chromium cobalt alloy stent (platform: flexia) rapid exchange delivery system biodegradable polymers drug everolimus eternia is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease in de novo coronary artery lesion in native coronary arteries with a reference vessel diameter of 2.25 mm to 4.50 mm and a lesion length ≤40 mm. Eternia is intended for use in patients eligible for percutaneous transluminal coronary angioplasty (ptca). Latest generation design of flexia (eternia platform) has unique geometry for controlled & distinctive stent expansion which enables low stent induced mechanical injury to arterial wall and excellent vessel conformability. Unique geometry of flexia platform allows everolimus drug to uniformly distribution over its length to control drug elution in a very precise manner which reduces the chances of restenosis.

We are an accomplished organization which has gained name and fame in providing Cartridge Syringe Aspyrating to the customers. Moreover, we offer these machines in various specifications.